KCNT2 Inhibitors

Chemical inhibitors of KCNT2 target the functionality of this sodium-activated potassium channel by various mechanisms. Quinidine, through its action as a blocker of voltage-gated potassium channels, inhibits KCNT2 by altering the membrane potential necessary for the opening of these channels. Similarly, clofilium tosylate and correolide bind to the potassium channel complex, stabilizing the closed state of the channel, thereby preventing the efflux of K+ ions crucial for KCNT2 function. Dendrotoxin and tertiapin exert their effects by specifically binding to potassium channels, thus obstructing the flow of potassium ions through KCNT2. This action directly impedes the channel's ability to conduct its normal function. Tetraethylammonium (TEA) is another classic potassium channel blocker that inhibits KCNT2 by blocking the potassium ion flow, thus directly inhibiting the channel's activity.

Further, slotoxin, which is specific to Slo2 potassium channels, can inhibit KCNT2 by altering its conductance and gating properties, effectively reducing the channel's activity. Paxilline, penitrem A, iberiotoxin, charybdotoxin, and apamin, although they primarily target other potassium channels like BK and SK channels, indirectly inhibit KCNT2. For instance, paxilline and penitrem A modify the calcium sensitivity and voltage-dependence of BK channels, which indirectly affects KCNT2 by preventing its activation. Iberiotoxin's action on BK channels affects the membrane potential, which is also crucial for KCNT2 activation and proper function. Charybdotoxin blocks the potassium channels by binding to their pore-forming alpha subunits, which would occlude the passage of K+ ions through KCNT2 as well. Apamin's effect on small conductance calcium-activated potassium channels leads to changes in the cellular environment, such as alterations in intracellular calcium levels, which can indirectly inhibit the normal functioning of KCNT2 by altering the electrochemical gradients it relies on.